Table of Contents

1 Industry Overview

• 1.1 Neuroprotection Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Neuroprotection
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Neuroprotection Market by Type

• 3.1 By Type
  • 3.1.1 Free Radical Trapping Agents (Antioxidants)
  • 3.1.2 Glutamate Antagonists (Anti-Excitotoxic Agents)
  • 3.1.3 Apoptosis Inhibitors
  • 3.1.4 Anti-inflammatory Agents
  • 3.1.5 Neurotrophic Factors (NTFs)
  • 3.1.6 Metal Ion Chelators
  • 3.1.7 Stimulants
  • 3.1.8 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Neuroprotection Daiichi Sankyo Company (Company Profile, Sales Data etc.)

• 4.2 Eli Lilly and Company (Company Profile, Sales Data etc.)
• 4.3 Allergan (Company Profile, Sales Data etc.)
• 4.4 Dr. Reddy’s Laboratories (Company Profile, Sales Data etc.)
• 4.5 Teva Pharmaceutical (Company Profile, Sales Data etc.)
• 4.6 Novartis (Company Profile, Sales Data etc.)
• 4.7 AstraZeneca (Company Profile, Sales Data etc.)
• 4.8 Astrocyte Pharmaceuticals (Company Profile, Sales Data etc.)
• 4.9 F. Hoffmann-La Roche (Company Profile, Sales Data etc.)
• 4.10 Biogen (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Prevention
  • 6.1.2 Demand in Treatment
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Neuroprotection

Table Application Segment of Neuroprotection

Table Global Neuroprotection Market 2013-2024, by Application, in USD Million

Table Major Company List of Free Radical Trapping Agents (Antioxidants)

Table Major Company List of Glutamate Antagonists (Anti-Excitotoxic Agents)

Table Major Company List of Apoptosis Inhibitors

Table Major Company List of Anti-inflammatory Agents

Table Major Company List of Neurotrophic Factors (NTFs)

Table Major Company List of Metal Ion Chelators

Table Major Company List of Stimulants

Table Major Company List of Others

Table Global Neuroprotection Market 2013-2018, by Type, in USD Million

Table Global Neuroprotection Market 2013-2018, by Type, in Volume

Table Global Neuroprotection Market Forecast 2019-2024, by Type, in USD Million

Table Global Neuroprotection Market Forecast 2019-2024, by Type, in Volume

Table Daiichi Sankyo Company Overview List

Table Neuroprotection Business Operation of Daiichi Sankyo Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly and Company Overview List

Table Neuroprotection Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Allergan Overview List

Table Neuroprotection Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Dr. Reddy’s Laboratories Overview List

Table Neuroprotection Business Operation of Dr. Reddy’s Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Teva Pharmaceutical Overview List

Table Neuroprotection Business Operation of Teva Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Novartis Overview List

Table Neuroprotection Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table Neuroprotection Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Astrocyte Pharmaceuticals Overview List

Table Neuroprotection Business Operation of Astrocyte Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table F. Hoffmann-La Roche Overview List

Table Neuroprotection Business Operation of F. Hoffmann-La Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Biogen Overview List

Table Neuroprotection Business Operation of Biogen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Neuroprotection Sales Revenue 2013-2018, by Company, in USD Million

Table Global Neuroprotection Sales Revenue Share, by Company, in USD Million

Table Global Neuroprotection Sales Volume 2013-2018, by Company, in Volume

Table Global Neuroprotection Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Neuroprotection Demand Forecast 2019-2024, by Application, in USD Million

Table Neuroprotection Demand Forecast 2019-2024, by Application, in Volume

Table Neuroprotection Production 2013-2018, by Region, in USD Million

Table Neuroprotection Production 2013-2018, by Region, in Volume

Table Global Neuroprotection Market 2013-2018, by Region, in USD Million

Table Global Neuroprotection Market Share 2013-2018, by Region, in USD Million

Table Global Neuroprotection Market 2013-2018, by Region, in Volume

Table Global Neuroprotection Market Share 2013-2018, by Region, in Volume

Table North America Neuroprotection Market Size 2013-2018, by Country, in USD Million

Table North America Neuroprotection Market Size 2013-2018, by Country, in Volume

Table Europe Neuroprotection Market Size 2013-2018, by Country, in USD Million

Table Europe Neuroprotection Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Neuroprotection Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Neuroprotection Market Size 2013-2018, by Country, in Volume

Table South America Neuroprotection Market Size 2013-2018, by Country, in USD Million

Table South America Neuroprotection Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Neuroprotection Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Neuroprotection Market Size 2013-2018, by Country, in Volume

Table Neuroprotection Market Forecast 2019-2024, by Region, in USD Million

Table Neuroprotection Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Neuroprotection Market Growth 2013-2018, by Type, in USD Million

Figure Global Neuroprotection Market Growth 2013-2018, by Type, in Volume

Figure North America Neuroprotection Market Concentration, in 2018

Figure Europe Neuroprotection Market Market Concentration, in 2018

Figure Asia-Pacific Neuroprotection MMarket Concentration, in 2018

Figure South America Neuroprotection Market Concentration, in 2018

Figure Middle East & Africa Neuroprotection Market Concentration, in 2018

Figure Neuroprotection Demand in Prevention, 2013-2018, in USD Million

Figure Neuroprotection Demand in Prevention, 2013-2018, in Volume

Figure Neuroprotection Demand in Treatment, 2013-2018, in USD Million

Figure Neuroprotection Demand in Treatment, 2013-2018, in Volume

Figure North America Neuroprotection Market Size and Growth 2013-2018, in USD Million

Figure North America Neuroprotection Market Size and Growth 2013-2018, in Volume

Figure Europe Neuroprotection Market Size and Growth 2013-2018, in USD Million

Figure Europe Neuroprotection Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Neuroprotection Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Neuroprotection Market Size and Growth 2013-2018, in Volume

Figure South America Neuroprotection Market Size and Growth 2013-2018, in USD Million

Figure South America Neuroprotection Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Neuroprotection Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Neuroprotection Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Neuroprotection market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neuroprotection by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Free Radical Trapping Agents (Antioxidants)
Glutamate Antagonists (Anti-Excitotoxic Agents)
Apoptosis Inhibitors
Anti-inflammatory Agents
Neurotrophic Factors (NTFs)
Metal Ion Chelators
Stimulants
Others
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Daiichi Sankyo Company
Eli Lilly and Company
Allergan
Dr. Reddy’s Laboratories
Teva Pharmaceutical
Novartis
AstraZeneca
Astrocyte Pharmaceuticals
F. Hoffmann-La Roche
Biogen
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Prevention
Treatment
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)